SREBF1 and fatty liver disease: Therefore, while SREBP1 and ChREBP are critical amplifiers of hepatic steatosis, the underlying metabolic perturbation—diversion of glucose from glycogen synthesis—provides a fundamental drive for the increase in lipid accumulation.